Cargando…
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression
Programmed death-1 (PD-1) is a cell surface receptor that functions as a T cell checkpoint and plays a central role in regulating T cell collapse. The binding of PD-1 to its ligand programmed death-ligand 1 (PD-L1) activates downstream signaling pathways and inhibits T cell activation in the perspec...
Autores principales: | Filippone, A., Lanza, M., Mannino, D., Raciti, G., Colarossi, C., Sciacca, D., Cuzzocrea, S., Paterniti, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374620/ https://www.ncbi.nlm.nih.gov/pubmed/35092481 http://dx.doi.org/10.1007/s00262-021-03130-z |
Ejemplares similares
-
Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management
por: Filippone, Alessia, et al.
Publicado: (2022) -
Interleukin-21 Influences Glioblastoma Course: Biological Mechanisms and Therapeutic Potential
por: Repici, Alberto, et al.
Publicado: (2023) -
TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma
por: Campolo, Michela, et al.
Publicado: (2020) -
Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
por: Hashimoto, Kazuhiko, et al.
Publicado: (2020) -
Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
por: Sharma, Meenal, et al.
Publicado: (2019)